Related Articles
The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice
Augmenter of liver regeneration ameliorates ischemia-reperfusion injury in steatotic liver via inhibition of the TLR4/NF-κB pathway
Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101
The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-κB signal transduction pathways
PPARγ activation reduces ischemia/reperfusion‑induced metastasis in a murine model of hepatocellular carcinoma